: iStockAnalyst.com Symbols Feed

Post Market Summary: Wall Street Rallies On Positive Data, Bank Of America (NYSE: BAC) Surges

Tue, 25 Aug 2009 22:16:22 GMT

US stocks finished with gains on Tuesday after better-than-expected consumer confidence and housing data boosted investor sentiment. Stocks also rose on reports that President Obama is nominating Federal Reserve chief Ben Bernanke for a second term in office.[More...]

Current Stock Prices: Why Trillions of Dollars on the Sidelines Maybe A Good Thing

Thu, 05 Feb 2009 17:28:00 GMT

Current Stock Prices: Why Trillions of Dollars on the Sidelines Maybe A Good Thing by Alexander Green, Oxford Club Investment Director You can’t blame most market investors for being nervous… The stock market has done a belly flop. Real estate keeps tumbling. The economy remains weak. Jobless claims recently hit a 26-year high. Investors have pulled tens of billions of dollars out of stocks and plunked it in the bank. We are optimistic, nonetheless. Why? Because the bad news is already reflected[More...]

Accuray (Nasdaq: ARAY): Stock of the Day

Mon, 02 Feb 2009 18:23:00 GMT

Accuray (Nasdaq: ARAY): Stock of the Day by Katharine Schildt, Assistant Editor, The Oxford Club The health care sector is about as recession-proof as you can get – quite an attractive quality in these trying times. According to some analysts health care could average a 25% gain this year. These gains are possible because our population is living longer as it grows older. That means more people suffering from harder-to-treat diseases longer. And disease’s poster-child is cancer. It claimed over 500,000 people in the United States alone last year. Cancer is one of the leading killers around the world as well. And even with recent gains in cancer treatment, the number of people suffering from this debilitating disease is expected to increase in coming[More...]

You Don’t Have To Go To Tunisia To Find Solid Stocks… They’re Right Here In The U.S.

Tue, 18 Nov 2008 22:34:00 GMT

Tuesday, November 18, 2008: Issue #576 by Marc Lichtenfeld, Senior Analyst & Healthcare Specialist, Smart Profits Report Today's eye-popping financial market statistic is brought to you by John Roque at Natixis Bleichroeder... Since the U.S. stock market peaked in October 2007, the world's equity market capitalization has shrunk by 53%. If you're counting ... [More...]

Analyst Comments: Union Pacific, Varian Semi, Petrobras, Marathon Oil, VimpelCom, Procter & Gamble, Accuray, Fushi, Micros Systems, RLI Corp

Wed, 17 Sep 2008 13:04:00 GMT

We are retaining our Hold on Union Pacific Corp. (UNP), as well as our $80 target price. UNP will report third quarter results on October 23. We are maintaining our 2008 diluted EPS estimate at $4.15, near the high end of management's increased $4.00-4.20[More...]

Analyst Comments: Net Servicos, Highwoods, Gushan Environmental Energy, Accuray, Optimer Pharmaceuticals

Wed, 09 Jul 2008 19:22:00 GMT

We are reiterating our Buy recommendation on Net Servicos (NETC). Although higher worldwide inflation and interest rates, particularly in Brazil, are source of great concern, we are highly encouraged by the company's solid operating results during the first quarter. We expect this trend to continue in the short term due to the still positive economic environment in Brazil. Brazil was...[More...]

Analyst Comments: Comstock, Applied Micro Circuits, Amkor Technology, Maxim, Accuray Incorporated

Wed, 07 May 2008 14:31:39 GMT

We are maintaining our Buy recommendation and raising our estimates and price target for Comstock Resources, Inc. (CRK) shares following the company's better-than-expected quarterly results. The out-performance was driven by production gains (up 25% year-[More...]

NASDAQ Technical Picture - Narrow Range Ahead of FED

Wed, 30 Apr 2008 06:06:27 GMT

Another choppy, mixed day ahead of the FED. Experts are calling for 0.25 BP cut and a statement discussing potential pause. I don't expect markets to rally on that news, but we'll soon see.[More...]

Analyst Comments: Clayton, ACE, Cosi, PetMed Express, Accuray, DRDGOLD, National Australia Bank, Meredith

Tue, 15 Apr 2008 17:35:30 GMT

On April 14, 2008, Clayton Holdings, Inc. (CLAY) announced that the company has signed a definitive agreement to be acquired by an affiliate of Greenfield Partners, LLC, a private equity firm. The agreement calls for the company to be acquired for $6 per share in cash, or approximately $134 million, plus the repayment of $23.8 million of Clayton's outstanding debt. The transaction...[More...]

Cancer Blaster vs. Surgical Robot?

Tue, 08 Jan 2008 20:01:00 GMT

The stock market is presenting all kinds of buying opportunities that are making me interested this week, but the one dynamic that stands out most today is the dramatic difference between the performance of two companies in my portfolio that sell high...[More...]

Shalov Stone Bonner & Rocco LLP Files Class Action Against Accuray Incorporated

Thu, 20 Aug 2009 04:47:00 GMT

Shalov Stone Bonner & Rocco LLP has filed a class action lawsuit on behalf of purchasers of the common stock of Accuray Incorporated ("Accuray" or the "Company") (NASDAQ: ARAY) between February 7, 2007 and August 19, 2008, inclusive (the "Class Period").
Also included are purchasers of Accuray common stock pursuant or traceable to the Company's Initial Public Offering on or about February 7, 2007.
The complaint alleges that, throughout the Class Period, the defendants made false and misleading statements concerning Accuray's financial performance, but failed to disclose that: Accuray amended its definition of backlog to include both contingent and non-contingent contracts; that a considerable percentage of contingent and non-contingent orders for the CyberKnife system that did not have a high probability of being booked as revenue were reported as backlog; Accuray's backlog was overstated by at least $127 million; Accuray sales personnel entered into contingent contracts for CyberKnife systems that did not have a high probability of being booked as revenue; the Company lacked adequate internal controls and procedures to ensure that potential orders reported as backlog had a substantially high probability of being booked as revenue; and that based on the foregoing, defendants did not have a reasonable basis for their positive statements about Accuray, its backlog, earnings, operations and prospects.

[More...]

Seventh CyberKnife System in South Korea Purchased

Wed, 12 Aug 2009 12:26:00 GMT

Accuray Incorporated , a global leader in the field of radiosurgery, today announced that the Gyeongsang National University Hospital in Jinju, South Korea has purchased a CyberKnife Robotic Radiosurgery System. This marks the seventh System sold in the country and its first equipped with the RoboCouch Patient Positioning System. GNUH is the first national university hospital in the country to purchase the System, allowing patients greater access to the benefits of radiosurgery.[More...]

Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Accuray Incorporated, Announces Class Action Lawsuit and Seeks to Recover Losses

Sat, 08 Aug 2009 04:50:00 GMT

Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for the Northern District of California on behalf of a class consisting of all persons or entities who purchased the common stock of Accuray Incorporated ("Accuray" or the "Company") (Nasdaq:ARAY) pursuant and/or traceable to the Company's Initial Public Offering commencing on or about February 7, 2007 (the "IPO"), including purchasers of the Company's common stock between February 7, 2007 and August 19, 2008, inclusive (the "Class Period").
A copy of the Complaint is available from the court or from Glancy Binkow & Goldberg LLP. Please contact us by phone to discuss this action or to obtain a copy of the Complaint at (310) 201-9150 or Toll Free at (888) 773-9224, by email at info@glancylaw.com, or visit our website at http://www.glancylaw.com.
The Complaint charges Accuray and certain of its executive officers and directors with violations of federal securities laws.

[More...]

Accuray Incorporated to Report Financial Results for Fourth Quarter and Fiscal Year 2009

Thu, 06 Aug 2009 02:27:00 GMT

Accuray Incorporated , a global leader in the field of radiosurgery, today announced that it will report results for its fourth quarter and fiscal year 2009, ended June 27, 2009, on Monday, August 24, 2009 after the market closes.[More...]

Shalov Stone Bonner &Amp; Rocco LLP Announces Class Action Against Accuray Incorporated

Wed, 05 Aug 2009 17:48:00 GMT

Shalov Stone Bonner & Rocco LLP announces that a class action lawsuit has been filed on behalf of purchasers of the common stock of Accuray Incorporated ("Accuray" or the "Company") (NASDAQ: ARAY) between February 7, 2007 and August 19, 2008, inclusive (the "Class Period").
Also included are purchasers of Accuray common stock pursuant or traceable to the Company's Initial Public Offering on or about February 7, 2007.
The complaint alleges that, throughout the Class Period, the defendants made false and misleading statements concerning Accuray's financial performance, but failed to disclose that: Accuray amended its definition of backlog to include both contingent and non-contingent contracts; that a considerable percentage of contingent and non-contingent orders for the CyberKnife system that did not have a high probability of being booked as revenue were reported as backlog; Accuray's backlog was overstated by at least $127 million; Accuray sales personnel entered into contingent contracts for CyberKnife systems that did not have a high probability of being booked as revenue; the Company lacked adequate internal controls and procedures to ensure that potential orders reported as backlog had a substantially high probability of being booked as revenue; and that based on the foregoing, defendants did not have a reasonable basis for their positive statements about Accuray, its backlog, earnings, operations and prospects.

[More...]

Shalov Stone Bonner & Rocco LLP Announces Class Action Against Accuray Incorporated

Wed, 05 Aug 2009 17:20:00 GMT

NEW YORK, NY -- -- 08/05/09 -- Shalov Stone Bonner & Rocco LLP announces that a class action lawsuit has been filed on behalf of purchasers of the common stock of Accuray Incorporated between February 7, 2007 and August 19, 2008, inclusive . Also included are purchasers of Accuray common stock pursuant or traceable to the Company's Initial Public Offering on or about February 7, 2007. The lawsuit is pending in the United States District Court for the Northern District of California.[More...]

Brower Piven Encourages Investors Who Have Losses in Excess of $200,000 From Investment in Accuray, Inc. To Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the September 21, 2009 Lead Plaintiff Deadline

Thu, 30 Jul 2009 21:46:00 GMT

Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Accuray, Inc. ("Accuray" or the "Company") (NASDAQ: ARAY) common stock pursuant or traceable to the Company's Initial Public Offering (the "IPO") on or about February 7, 2007, as well as purchasers of the Company's common stock between February 7, 2007 and August 19, 2008, inclusive (the "Class Period").
No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 and the Securities Act of 1933 by virtue of the Company's failure to disclose in the registration statement issue for its initial public offering ("IPO") on or about February 7, 2007 and/or during the Class Period that at the time of Accuray's IPO, Accuray changed its definition of backlog to include both contingent and non-contingent contracts such that, beginning in the fiscal quarter ending March 31, 2007 (the time of the IPO), the total reported backlog would increase and be materially overstated because the backlog orders for the CyberKnife system did not have a substantially high probability of being booked as revenue while a significant portion of commissions paid to CyberKnife sales personnel were earned prior to those potential sales being booked as revenue.

[More...]

Kendall Law Group Announces Class Action Against Accuray

Thu, 30 Jul 2009 17:08:00 GMT

DALLAS, TX -- -- 07/30/09 -- Kendall Law Group, led by a former federal judge and U.S. Attorney, announces that a lawsuit has been filed on behalf of Accuray shareholders who purchased stock between February 7, 2007 and August 19, 2008. Also included are those who purchased common stock pursuant or traceable to the Company's Initial Public Offering on February 7, 2007.[More...]

Accuray Announces CyberKnife Access Remote Service Product

Sun, 26 Jul 2009 12:26:00 GMT

Accuray Incorporated , a global leader in the field of radiosurgery, announced today the launch of the CyberKnife Access) Remote Service product, a real-time customer service and support offering for the CyberKnife) Robotic Radiosurgery System. This and other Accuray technologies will be highlighted during the 51st Annual Meeting of The American Association of Physicists in Medicine, July 26-30, 2009 in Anaheim, Calif.CyberKnife Access utilizes the Axeda )ServiceLink technology to provide a remote service solution for the devices that make up CyberKnife Systems at customer sites. This Remote Service offering enables Accuray's team of highly trained engineers and customer support technicians to diagnose and address service needs from a remote location using a secure internet connection. The result is real-time support, allowing for a quick customer response without a site visit, thereby enhancing operational efficiencies. 'With CyberKnife Access a simple issue can be diagnosed remotely so that a replacement part can be ordered before the engineer even arrives on site,' said Jeff Snyder, manager of Radiation Oncology and CyberKnife at Southwest Washington Medical Center in Vancouver, Wash. 'It's reassuring to know that when you have a patient coming in for treatment and a service need arises, a lifeline exists so you can get their treatment going without delay.' "We strive to provide the highest level of service and support to our customers," said Chris Raanes, senior vice president and chief operating officer at Accuray. "With CyberKnife Access, we're now able to provide faster and easier servicing to help our customers resume treatments with minimal interruptions to patient care.' Axeda has delivered remote service solutions to more than 20 of the world's leading medical and life science manufacturers. Axeda ServiceLink enables companies to securely monitor the health and performance of their products from anywhere in the world, while helping them comply with industry regulations such as HIPAA and 21 CFR Part 11.About AxedaAxeda Corporation delivers secure remote service and support capabilities to some of the world's leading manufacturing companies and large enterprises. The award-winning Axeda ServiceLink solution helps companies, including Abbott Laboratories, Diebold and EMC, proactively service and support products to drive optimal uptime at the lowest possible cost, while enabling enterprises to effectively secure, control and track all remote access to critical data centers. In 2006, Axeda became the first and only remote service application provider to receive the prestigious VeriSign Security Certification. Axeda Corporation is a privately held company headquartered in Foxboro, Mass. and can be reached at www.axeda.com.About the CyberKnife) Robotic Radiosurgery SystemThe CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.About AccurayAccuray Incorporated , based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 60,000 patients worldwide and currently more than 164 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com. Safe Harbor Statement The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to commercialization of products, clinical studies, and regulatory review and approval are forward-looking statements within the meaning of the "safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for the 2008 fiscal year, as updated in our Form 10-Q filed on May 6, 2009 and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.Available Topic Experts: For information on the listed experts, click appropriate link.Euan Thomson, Ph.D. https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869Omar Dawood, M.D., MPH https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=85068[More...]

First Customer Installs CyberKnife System in Existing Radiation Therapy Vault

Fri, 24 Jul 2009 12:26:00 GMT

Accuray Incorporated , a global leader in the field of radiosurgery, announced today that CyberKnife Center of Chicago at Elmhurst Memorial Hospital in Elmhurst, Ill., has installed the CyberKnife) Robotic Radiosurgery System in one of the hospital's existing radiation therapy vaults. This marks the first installation of this new CyberKnife configuration option, which can save hospitals both time and money.'We are excited about the new CyberKnife configuration and its ability to fit into an existing vault, because it requires significantly less modification and has allowed us to get the System up and running more quickly so we can begin treating patients,' said Greg Spurlock, chief operating officer of US Radiosurgery, the managing partner of CyberKnife Center of Chicago.Because radiation therapy systems are gantry-based machines, meaning they only rotate in a single rotational plane, radiation therapy vaults are typically smaller and require less shielding than a standard CyberKnife vault. Since a key factor in the CyberKnife System's precise treatment delivery is its ability to move in virtually any direction, it wasn't previously possible to install a CyberKnife System within a radiation therapy vault. Recognizing that this was an obstacle for many hospitals, Accuray used advanced optimization techniques to reconfigure a new layout that made this type of installation possible with minimal-to-no additional shielding.The new footprint helps hospitals to save on construction and shielding costs, and enables an accelerated go-live schedule, allowing sites to start patient treatments within a significantly shorter period of time. This is particularly beneficial for sites that are interested in securing a CyberKnife System to replace an aging gantry-based radiation therapy system, but are faced with space constraints in their existing facilities or are unable to build a new facility.The new CyberKnife configuration made this vault modification and installation possible in just five weeks,' said Chris Raanes, senior vice president and chief operating officer at Accuray. 'Now hospitals can go-live with their CyberKnife program very quickly and for a fraction of the cost.'With feature nearly identical to the standard CyberKnife vault layout, the gantry LINAC vault layout requires 34 percent less vault space and reduces the equipment room footprint, giving customers more flexibility in where they can place a CyberKnife System. The vault modifications at this center were done by one of Accuray's installation preferred partners, NELCO. Vendors in this program have the expertise and resources to efficiently support customers with any required construction and modifications.About the CyberKnife) Robotic Radiosurgery SystemThe CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.About AccurayAccuray Incorporated , based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 60,000 patients worldwide and currently more than 164 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com. Safe Harbor StatementThe foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to commercialization of products, clinical studies, and regulatory review and approval are forward-looking statements within the meaning of the "safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for the 2008 fiscal year, as updated in our Form 10-Q filed on May 6, 2009 and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.[More...]